Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03799341 · ClinicalTrials.gov registry record · NA
Neurocognitive Factors in Substance Use Treatment Response: The Ways of Rewarding Abstinence Project
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT03799341: Completed NA study, sponsored by VA Office of Research and Development.
NCT03799341 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03799341, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
The proposed work will investigate changes in brain signaling and cognitive functioning that support recovery from addiction, as well as use of pretreatment neurocognitive functioning to inform substance use treatment planning. Substance use disorders are prevalent amongst Veterans. Cocaine addiction, in particular, has been shown to complicate treatment of other high priority behavioral health problems in the Veteran population (e.g., PTSD, opioid addiction). While there are currently no approved medications to support recovery from cocaine addiction, research indicates that Contingency Management (CM) - a behavioral intervention for cocaine users - can be effective. However, individual responses are variable and long-term benefits are limited. This CDA will test a new model of how CM works by examining brain-based predictors and indicators of treatment response. Results will have immediate implications for measurement-based implementation of existing CM variants within the VA, supporting access to the version of CM that is best aligned with each Veteran's needs.
Interventions
- BEHAVIORAL Prize-Based Contingency Management
- BEHAVIORAL Treatment As Usual Outpatient Substance Use Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2019-11-13 |
| Est. Completion | 2024-04-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03799341
The ClinicalTrials.gov registry entry for NCT03799341 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prize-Based Contingency Management is the first listed.
NCT03799341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03799341 about?
NCT03799341 is a clinical study titled "Neurocognitive Factors in Substance Use Treatment Response: The Ways of Rewarding Abstinence Project". The proposed work will investigate changes in brain signaling and cognitive functioning that support recovery from addiction, as well as use of pretreatment neurocognitive functioning to inform substance use treatment planning. Substance use disorders are prevalent amongst Veterans. Cocaine addictio...
What is the current status of trial NCT03799341?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2019-11-13. Estimated completion is 2024-04-12.
What interventions are being tested in trial NCT03799341?
The interventions under investigation include: Prize-Based Contingency Management (BEHAVIORAL), Treatment As Usual Outpatient Substance Use Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03799341?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.